Clinical Trial Update: A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets [Phase 2]

View source ↗

Summary

A Phase 2 multicenter trial evaluating neoadjuvant therapy with Ivosimab plus chemotherapy for resectable colorectal cancer with liver metastases; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Ivosimab (ivosimab)

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Colorectal Cancer With Liver Metastasis | Phase 2 | Status: NOT_YET_RECRUITING